The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

Unlike the array of new injectable GLP-1 drugs, there is only one oral GLP-1 medicine that is currently on the market: Novo Nordisk’s Rybelsus. This semaglutide pill mimics the gut hormone GLP-1 ...

GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...

Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...

My dad, Michael Mosley, was an inspiration to millions of people worldwide – particularly those living with obesity or type 2 ...

Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.